ImmunityBio
IBRX
$2.63
Share price
6.91%
Change (1 day)
-56.60%
Change (1 year)
Categories
Revenue for ImmunityBio (IBRX)
Revenue in 2024 (TTM): $14.74 Million USD
According to ImmunityBio's latest financial reports the company's current revenue (TTM 
) is $14.74 Million USD. an increase over the revenue in the year 2023 that were of $0.62 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for ImmunityBio from 2020 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | $14.74 M | 2270.58% |
| 2023 | $0.62 M | 159.17% |
| 2022 | $0.24 M | -74.3% |
| 2021 | $0.93 M | 54.38% |
| 2020 | $0.6 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |